John Chou Biography and Net Worth

EVP of Cencora

John G. Chou is Executive Vice President and Chief Legal Officer for AmerisourceBergen Corporation. In this role, he is responsible for legal, regulatory, corporate security, global business resilience and enterprise risk management. Previously, Mr. Chou served as Chief Legal & Business Officer from 2017 to 2019, with executive management responsibility of strategy, business development, innovation, legal and compliance functions. Prior to this, Mr. Chou was Executive Vice President and General Counsel of AmerisourceBergen Corporation.

Before joining AmerisourceBergen in 2002, Mr. Chou was a partner with a large Philadelphia law firm. He has been practicing law for over 35 years and previously held senior legal positions both in-house and in private practice in the United States and the United Kingdom.

Mr. Chou is a graduate of Harvard College and the University of Pennsylvania Law School. Actively involved in the community, his board affiliations and memberships include the Episcopal Community Services Board of Trustees and the Committee of Seventy Board of Directors.

What is John G. Chou's net worth?: The estimated net worth of John G. Chou is at least $17.93 million as of August 19th, 2021. Mr. Chou owns 73,182 shares of Cencora stock worth more than $17,931,054 as of November 23rd. This net worth approximation does not reflect any other investments that Mr. Chou may own. Learn More about John G. Chou's net worth.
How do I contact John G. Chou?: The corporate mailing address for Mr. Chou and other Cencora executives is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. Cencora can also be reached via phone at (610) 727-7000 and via email at [email protected]. Learn More on John G. Chou's contact information.
Has John G. Chou been buying or selling shares of Cencora?: John G. Chou has not been actively trading shares of Cencora during the last quarter. Most recently, John G. Chou sold 6,081 shares of the business's stock in a transaction on Thursday, August 19th. The shares were sold at an average price of $117.94, for a transaction totalling $717,193.14. Following the completion of the sale, the executive vice president now directly owns 73,182 shares of the company's stock, valued at $8,631,085.08. Learn More on John G. Chou's trading history.
Who are Cencora's active insiders?: Cencora's insider roster includes Silvana Battaglia (EVP), Elizabeth Campbell (EVP), John Chou (EVP), Gina Clark (EVP), Gina Clark (EVP), Steven Collis (CEO), Leslie Donato (EVP), Leslie Donato (EVP), Jeffrey Finnin (CFO), Juan Font (SVP), Jane Henney, MD (Director), Mark Jones (CAO), Maile Kaiser (SVP), Michael Koehler (Director), Lazarus Krikorian (CAO), Aleksandra Krusko (SVP), Robert Mauch (EVP), Robert Mauch (COO), Derek McCandless (SVP), Henry McGee, III (Director), Steven Smith (CRO), Paul Szurek (CEO), and Brian Warren (SVP). Learn More on Cencora's active insiders.
Are insiders buying or selling shares of Cencora?: During the last year, Cencora insiders bought shares 1 times. They purchased a total of 500 shares worth more than $109,290.00. During the last year, insiders at the sold shares 16 times. They sold a total of 10,700,964 shares worth more than $2,502,728,286.19. The most recent insider tranaction occured on November, 19th when Chairman Steven H Collis sold 21,509 shares worth more than $5,208,619.44. Insiders at Cencora own 15.8% of the company. Learn More about insider trades at Cencora.
Information on this page was last updated on 11/19/2024.

John G. Chou Insider Trading History at Cencora

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/19/2021	Sell	6,081	$117.94	$717,193.14	73,182
7/19/2021	Sell	6,082	$112.09	$681,731.38	73,183
6/18/2021	Sell	6,082	$117.23	$712,992.86	73,183
4/19/2021	Sell	6,082	$120.00	$729,840.00	73,183
3/19/2021	Sell	6,082	$115.35	$701,558.70	73,183
10/15/2020	Sell	5,602	$97.89	$548,379.78	57,397
9/15/2020	Sell	5,602	$94.88	$531,517.76
7/15/2020	Sell	5,602	$100.43	$562,608.86	57,397
6/15/2020	Sell	5,603	$93.44	$523,544.32
11/5/2019	Sell	13,997	$86.07	$1,204,721.79
10/7/2019	Sell	13,997	$81.48	$1,140,475.56	65,782
9/5/2019	Sell	13,997	$86.29	$1,207,801.13	65,782
8/5/2019	Sell	13,997	$89.58	$1,253,851.26	65,782
2/15/2019	Sell	6,974	$86.70	$604,645.80	58,759
1/15/2019	Sell	6,974	$76.99	$536,928.26	58,759
12/14/2018	Sell	6,974	$80.78	$563,359.72	58,759
11/15/2018	Sell	6,974	$88.51	$617,268.74	58,426
10/15/2018	Sell	6,974	$88.07	$614,200.18	56,125
9/14/2018	Sell	6,974	$86.19	$601,089.06	56,125
8/15/2018	Sell	6,974	$83.94	$585,397.56	56,126
2/1/2018	Sell	15,939	$97.74	$1,557,877.86	67,228
12/1/2017	Sell	15,937	$82.42	$1,313,527.54	67,226
11/6/2017	Sell	15,937	$74.50	$1,187,306.50	57,924
8/31/2016	Sell	63,750	$85.70	$5,463,375.00	104,043
5/8/2015	Sell	78,656	$115.24	$9,064,317.44
2/6/2015	Sell	21,460	$97.70	$2,096,642.00

John G. Chou Buying and Selling Activity at Cencora

Cencora Company Overview

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Today's Range

Now: $245.02

$244.65

$247.55

50 Day Range

MA: $233.12

$219.50

$249.95

2 Week Range

Now: $245.02

$195.83

$251.56

Volume

942,788 shs

Average Volume

1,400,130 shs

Market Capitalization

$48.28 billion

P/E Ratio

32.63

Dividend Yield

0.91%

Beta

0.44

Trump’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW